Cancer of the Lung

Despite recent advances in our understanding of lung cancer and the implementation of many new preventive measures, this terrible disease remains the leading cause of cancer deaths in the United States, as well as a major cause of such deaths worldwide. In Cancer of the Lung: From Molecular Biology to Treatment Guidelines, Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss already well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs, including those entailed by malpractice litigation. §Comprehensive and highly readable, Cancer of the Lung: From Molecular Biology to Treatment Guidelines offers today's oncologists, internists, and residents not only a clear and concise introduction to its molecular biology, but also a state-of-the-art practical review of all the current and developing diagnostic and treatment options for patients. Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs.